FDA head Makary defends drug application rejections amid criticism
Replimune Group, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $8.69
+72% in 7d after detection
Post-detection moves
1h
—
1d
+20%
3d
+42%
7d
+72%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS